RITTER PHARMACEUTICALS INC Human Resources Contracts & Agreements
28 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Change of Control Agreements (6)
- Compensation Agreements (1)
- Consulting Agreements (8)
- Employment Agreements (4)
- Separation Agreements (1)
- Consulting Agreement, between the Company and IR Agency, LLC (Filed With SEC on October 24, 2024)
- Separation Agreement and General Release, dated June 20, 2023, by and between Qualigen Therapeutics, Inc. and Amy Broidrick (Filed With SEC on August 14, 2023)
- Amendment No. 2 to the 2020 Stock Incentive Plan of Qualigen Therapeutics, Inc (Filed With SEC on November 22, 2022)
- Executive Employment Agreement dated December 10, 2021 with Amy Broidrick (Filed With SEC on March 31, 2022)
- Amendment to 2020 Stock Incentive Plan (approved by the Board of Directors on April 27, 2021 and by the Stockholders on August 9, 2021) (Filed With SEC on November 15, 2021)
- Standard template of Stock Option Agreement for use under 2020 Stock Incentive Plan (Filed With SEC on June 11, 2020)
- 2020 Stock Equity Incentive Plan (Filed With SEC on May 29, 2020)
- Consulting Agreement, by and between the Company and CFB Financial, Inc., dated as of May 22, 2020 (Filed With SEC on May 29, 2020)
- Consulting Agreement, by and between the Company and Stonehenge Partners, LLC, dated as of May 22, 2020 (Filed With SEC on May 29, 2020)
- Consulting Agreement, by and between the Company and Andrew J. Ritter, dated as of May 22, 2020 (Filed With SEC on May 29, 2020)
- Amendment No. 2 to Consulting Agreement, by and between Qualigen, Inc. and GreenBlock Capital LLC, dated as of May 3, 2020 (Filed With SEC on May 29, 2020)
- Amendment to Consulting Agreement, by and between Qualigen, Inc. and GreenBlock Capital LLC, dated as of March 6, 2020 (Filed With SEC on May 29, 2020)
- Consulting Agreement, by and between Qualigen, Inc. and GreenBlock Capital LLC, dated as of August 22, 2018 (Filed With SEC on May 29, 2020)
- Executive Employment Agreement, by and between Qualigen, Inc. and Shishir Sinha, dated as of February 1, 2017 and as amended on January 9, 2018 (Filed With SEC on May 29, 2020)
- Executive Employment Agreement, by and between Qualigen, Inc. and Christopher Lotz, dated as of February 1, 2017 and as amended on January 9, 2018 (Filed With SEC on May 29, 2020)
- Executive Employment Agreement, by and between Qualigen, Inc. and Michael Poirier, dated as of February 1, 2017 and as amended on January 9, 2018 (Filed With SEC on May 29, 2020)
- Form of Performance Restricted Stock Unit Award Agreement (Filed With SEC on April 1, 2019)
- Consulting Agreement, dated June 26, 2018, by and between Ritter Pharmaceuticals, Inc. and Michael D. Step (Filed With SEC on July 2, 2018)
- Executive Severance and Change in Control Agreement, by and between the Company and John W. Beck, effective May 24, 2018 (Filed With SEC on May 29, 2018)
- Amendment to 2015 Equity Incentive Plan (Filed With SEC on September 15, 2017)
- AMENDMENTTO 2015 EQUITY INCENTIVE PLAN (EffectiveJune 3, 2016) (Filed With SEC on June 6, 2016)
- EXECUTIVE SEVERANCE & CHANGE IN CONTROL AGREEMENT (Filed With SEC on August 12, 2015)
- EXECUTIVE SEVERANCE & CHANGE IN CONTROL AGREEMENT (Filed With SEC on August 12, 2015)
- EXECUTIVE SEVERANCE & CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 22, 2015)
- EXECUTIVE SEVERANCE & CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 22, 2015)
- RITTER PHARMACEUTICALS, INC. 2015 EQUITY INCENTIVE PLAN ARTICLE1. PURPOSE (Filed With SEC on May 8, 2015)
- EXECUTIVE SEVERANCE & CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 23, 2015)
- Ritter Pharmaceuticals, Inc. Executive Compensation Plan (Filed With SEC on March 23, 2015)
